President, Chief Executive Officer and Director; formerly CEO, Tiburio Therapeutics, Rapport Therapeutics
Search every verified Abe Ceesay interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a September 2026 interview with Sofinnova, Rapport Therapeutics CEO Abe Ceesay discussed the company's work in precision neuroscience and its lead program, RAP-219, for focal onset seizures. Ceesay described the current period as a unique moment for neuroscience, noting that investment has returned to the field after a period of focus on metabolic disease and oncology. He credited Sofinnova's investment team with a strong understanding of neuroscience and said their reputation has helped attract other high-quality investors. Ceesay also recounted receiving a letter from a patient and their family stating that after taking the company's drug, the patient was seizure-free for the first time in their life. He described the letter as one of the most touching moments of his career and said it motivated the company. Looking ahead, Ceesay predicted that the next 50 years will bring the greatest innovation biotech has ever seen, resulting in people living longer, healthier, and more fulfilling lives.
We sat down with Rapport Therapeutics CEO Abraham (Abe) Ceesay to discuss the company's approach to precision neuroscience and its work developing a new generation of medicines for neurological and psychiatric disorders.
Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.
Abraham Ceesay, president of Rapport Therapeutics, urges the class of 2023 to consider the importance of community and their roles in building and sustaining those to which they belong.
Sign in to search the full transcript archive, filter by topic, and access every quote from Abe Ceesay.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans